Yeast-two-hybrid based high-throughput screening to discover SARS-CoV-2 fusion inhibitors by targeting the HR1/HR2 interaction.
- DOI
- 10.1016/j.apsb.2025.06.029
- Published
- 2025 Sep
- Container
- Acta pharmaceutica Sinica. B
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2025.06.029,
title = {Yeast-two-hybrid based high-throughput screening to discover SARS-CoV-2 fusion inhibitors by targeting the HR1/HR2 interaction.},
author = {Zhang J and Li D and Zhou W and Liu C and Wang P and You B and Su B and Guo K and Shi W and Timothy Yung TM and Tsun Kao RY and Gao P and Li Y and Si S},
year = {2025},
journal = {Acta pharmaceutica Sinica. B},
doi = {10.1016/j.apsb.2025.06.029},
url = {https://doi.org/10.1016/j.apsb.2025.06.029}
}RIS
TY - JOUR TI - Yeast-two-hybrid based high-throughput screening to discover SARS-CoV-2 fusion inhibitors by targeting the HR1/HR2 interaction. AU - Zhang J AU - Li D AU - Zhou W AU - Liu C AU - Wang P AU - You B AU - Su B AU - Guo K AU - Shi W AU - Timothy Yung TM AU - Tsun Kao RY AU - Gao P AU - Li Y AU - Si S PY - 2025 JO - Acta pharmaceutica Sinica. B DO - 10.1016/j.apsb.2025.06.029 UR - https://doi.org/10.1016/j.apsb.2025.06.029 ER -
APA
J, Z., D, L., W, Z., C, L., P, W., B, Y., B, S., K, G., W, S., TM, T. Y., RY, T. K., P, G., Y, L., & S, S. (2025). Yeast-two-hybrid based high-throughput screening to discover SARS-CoV-2 fusion inhibitors by targeting the HR1/HR2 interaction.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2025.06.029
Source records
- pubmed · retrieved 2026-09-25T07:00:09.086Z